X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (657) 657
Conference Proceeding (51) 51
Book Review (32) 32
Publication (25) 25
Book / eBook (11) 11
Book Chapter (10) 10
Patent (7) 7
Magazine Article (3) 3
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (234) 234
female (147) 147
index medicus (127) 127
male (122) 122
adult (109) 109
middle aged (102) 102
aged (80) 80
oncology (64) 64
radiology, nuclear medicine & medical imaging (60) 60
magnetic resonance imaging (47) 47
plant sciences (45) 45
forestry (44) 44
life sciences (44) 44
plant ecology (44) 44
medicine & public health (39) 39
treatment outcome (39) 39
surgery (33) 33
algorithms (31) 31
chemotherapy (31) 31
magnetic resonance imaging - methods (31) 31
aged, 80 and over (30) 30
analysis (25) 25
retrospective studies (24) 24
adolescent (23) 23
breast cancer (23) 23
breast neoplasms - drug therapy (23) 23
research (23) 23
animals (22) 22
cancer (22) 22
care and treatment (22) 22
mri (22) 22
young adult (22) 22
trastuzumab (21) 21
time factors (20) 20
breast neoplasms - pathology (19) 19
orthopedics (19) 19
reproducibility of results (19) 19
prognosis (18) 18
chemistry (17) 17
diagnosis (17) 17
image enhancement - methods (17) 17
magnetic resonance spectroscopy - methods (17) 17
metastasis (17) 17
mr spectroscopy (17) 17
sensitivity and specificity (17) 17
antineoplastic agents - therapeutic use (16) 16
heart (16) 16
prospective studies (16) 16
quantification (16) 16
research article (16) 16
antibodies, monoclonal - therapeutic use (15) 15
antibodies, monoclonal, humanized (15) 15
myocardium - metabolism (15) 15
physiological aspects (15) 15
risk factors (15) 15
therapy (15) 15
computer simulation (14) 14
disease-free survival (14) 14
immunohistochemistry (14) 14
mathematics (14) 14
mice (14) 14
monoclonal-antibody (14) 14
proteins (14) 14
tumors (14) 14
breast neoplasms - metabolism (13) 13
cardiac & cardiovascular systems (13) 13
disease (13) 13
follow-up studies (13) 13
gene expression (13) 13
magnetic resonance spectroscopy (13) 13
reconstruction (13) 13
usage (13) 13
article (12) 12
computer science (12) 12
image interpretation, computer-assisted - methods (12) 12
internal medicine (12) 12
medicine (12) 12
receptor, erbb-2 - metabolism (12) 12
virology (12) 12
biochemistry & molecular biology (11) 11
child (11) 11
dermatology (11) 11
magnetic-resonance (11) 11
phantoms, imaging (11) 11
abridged index medicus (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
case-control studies (10) 10
chemistry, analytical (10) 10
expression (10) 10
imaging / radiology (10) 10
management (10) 10
methods (10) 10
models (10) 10
myocardium (10) 10
neoplasm metastasis (10) 10
polymers (10) 10
spectroscopy (10) 10
cells (9) 9
chemistry, multidisciplinary (9) 9
development and progression (9) 9
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (2) 2
Art - Library use only (1) 1
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2013, Volume 141, Issue 1, pp. 43 - 53
Trastuzumab is effective in the treatment of HER2/neu over-expressing breast cancer, but not all patients benefit from it. In vitro data suggest a role for... 
p95HER2 | Medicine & Public Health | Oncology | Breast cancer | HER2 | Trastuzumab | HER3 | ADJUVANT CHEMOTHERAPY | EFFICACY | SAFETY | QUANTITATION | MONOCLONAL-ANTIBODY | PERTUZUMAB | FAMILY | ONCOLOGY | COHORT | PLUS | Single-Blind Method | Breast Neoplasms - secondary | Prognosis | Receptor, ErbB-2 - genetics | Receptor, ErbB-3 - analysis | Humans | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Breast Neoplasms - metabolism | Receptor, ErbB-3 - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Peptide Fragments - immunology | Female | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - immunology | Retrospective Studies | Neoplasm Proteins - genetics | Antibodies, Monoclonal - immunology | Fluorescent Antibody Technique, Indirect | Breast Neoplasms - classification | Protein Structure, Tertiary | Antibodies, Monoclonal, Humanized - therapeutic use | Biomarkers, Tumor - analysis | Neoplasm Proteins - biosynthesis | Kaplan-Meier Estimate | Treatment Outcome | Receptor, ErbB-3 - genetics | Breast Neoplasms - drug therapy | Peptide Fragments - analysis | Disease-Free Survival | Breast Neoplasms - genetics | Genes, erbB-2 | Cell Line, Tumor | Breast Neoplasms - mortality | Biomarkers, Tumor - genetics | Decision Trees | Receptor, ErbB-2 - analysis | Biomarkers, Tumor - immunology | Cohort Studies | Care and treatment | Metastasis | Cancer | Preclinical Study
Journal Article
Oncogene, ISSN 0950-9232, 02/2012, Volume 31, Issue 7, pp. 907 - 917
A large fraction of ductal carcinoma in situ ( DCIS), a non-invasive precursor lesion of invasive breast cancer, overexpresses the HER2/neu oncogene. The ducts... 
growth factor | breast cancer | receptor tyrosine kinase | spheroids | signal transduction | DCIS | 3-DIMENSIONAL CULTURES | ACTIVATION | HUMAN-BREAST-CANCER | NEU ONCOGENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | NOTCH | MONOCLONAL-ANTIBODY | CELL BIOLOGY | OVEREXPRESSION | EPITHELIAL-CELLS | ONCOLOGY | MAMMARY-GLAND DEVELOPMENT | GENETICS & HEREDITY | STEM-CELL | Cell Proliferation | Epithelial Cells - metabolism | Oligonucleotide Array Sequence Analysis | Receptor, ErbB-2 - genetics | Receptors, Notch - metabolism | Epithelial Cells - drug effects | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Receptor, ErbB-2 - metabolism | Immunoblotting | Receptors, Notch - genetics | Carcinoma, Intraductal, Noninfiltrating - genetics | Gene Expression Profiling | Green Fluorescent Proteins - genetics | Mammary Glands, Human - metabolism | Breast Neoplasms - metabolism | Transfection | RNA Interference | HEK293 Cells | Female | Cell Line | Green Fluorescent Proteins - metabolism | Mammary Glands, Human - cytology | Mice, Transgenic | Signal Transduction - genetics | Reverse Transcriptase Polymerase Chain Reaction | Microscopy, Confocal | Animals | Breast Neoplasms - genetics | Models, Biological | Receptor, Notch3 | Mice | Epidermal Growth Factor - pharmacology | Carcinoma, Ductal | Physiological aspects | Genetic aspects | Research | Risk factors | Oncogenes | Apoptosis | Proteins | Signal transduction | Breast cancer | Cellular biology | Gene expression | Cell proliferation | Integration | Carcinoma | Cell survival | Transcription | Epithelial cells | Invasiveness | c-Myc protein | ErbB-2 protein | Transgenic animals | Extracellular matrix | Notch protein | cyclin D1 | Mammary gland | Tumors
Journal Article
Progress in Photovoltaics: Research and Applications, ISSN 1062-7995, 05/2010, Volume 18, Issue 3, pp. 155 - 159
The epitaxial lift‐off (ELO) technique can be used to separate a III–V solar cell structure from its underlying GaAs or Ge substrate. ELO from 4‐inch Ge wafers... 
III–V | thin‐film | substrate reuse | III-V | Thin-film | Substrate reuse | EPITAXIAL LIFT-OFF | thin-film | PHYSICS, APPLIED | ENERGY & FUELS | EFFICIENCY | LAYERS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2010, Volume 16, Issue 16, pp. 4226 - 4235
Journal Article
Cancer Research, ISSN 0008-5472, 03/2011, Volume 71, Issue 5, pp. 1871 - 1882
Journal Article
Oncogene, ISSN 0950-9232, 07/2012, Volume 31, Issue 30, pp. 3505 - 3515
Epidermal growth factor (EGF)-like growth factors control tumor progression as well as evasion from the toxic effects of chemotherapy. Accordingly, antibodies... 
growth factor | cancer therapy | EGF | signal transduction | tyrosine kinase | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-LINES | FACTOR RECEPTOR | FACTOR-ALPHA | CELL BIOLOGY | BREAST-CANCER | CORRESPONDING PRIMARY TUMORS | LUNG-CANCER | ONCOLOGY | IN-VIVO | SIGNALING NETWORK | GENETICS & HEREDITY | CARCINOMA | Lung Neoplasms - drug therapy | Humans | Receptor, ErbB-2 - chemistry | Recombinant Fusion Proteins - therapeutic use | Receptor, ErbB-2 - metabolism | Antineoplastic Agents - therapeutic use | Recombinant Fusion Proteins - chemistry | Mice, SCID | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Adenocarcinoma - secondary | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Animals | Lung Neoplasms - secondary | Breast Neoplasms - pathology | Mice, Nude | Cell Line, Tumor | Female | Cell Proliferation - drug effects | Mice | Receptor, ErbB-4 | Embryonic development | Control | Care and treatment | Epidermal growth factor | Physiological aspects | Metastasis | Research | Gene expression | Oncology | Chemotherapy | Genetic recombination | Tumors | Index Medicus | ErbB-1 protein | Epidermal growth factor receptors | ErbB protein | Invasiveness | Tumor cells | Lung | Antibodies | ErbB-2 protein | Metastases | ErbB-4 protein | Xenografts | Mammary gland | Fusion protein | Cancer
Journal Article
Oncogene, ISSN 0950-9232, 08/2012, Volume 31, Issue 31, pp. 3569 - 3583
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0172911
Journal Article